Body Fluid Analysis for Cellular Composition (H56-A); Use of External RNA Controls in Gene Expression Assays (MM16-A); Point-of-Care Connectivity (POCT1-A2); Point-of-Care In Vitro Diagnostic (IVD) Testing (POCT4-A2)

MM16-A—Use of External RNA Controls in Gene Expression Assays; Approved Guideline
This document provides protocols supporting the use of external RNA controls in microarray and QRT-PCR-based gene expression experiments, including preparation of control transcripts, design of primers and amplicons, quality control, use in final experimental or clinical test application, and analysis and interpretation of data obtained. A CLSI–IFCC joint project.
Purchase here.

POCT4-A2—Point-of-Care In Vitro Diagnostic (IVD) Testing; Approved Guideline – Second Edition
This document provides guidance to users of in vitro diagnostic (IVD) devices outside the clinical laboratory, to ensure reliable results comparable to those obtained within the clinical laboratory. Replaces AST2-A.
Purchase here.

Second Notice

H56-A—Body Fluid Analysis for Cellular Composition; Approved Guideline
This guideline provides users with recommendations for collection and transport of body fluids, numeration and identification of cellular components, and guidance for qualitative and quantitative assessment of body fluid. A CLSI-IFCC joint project.
Purchase here.

POCT1-A2—Point-of-Care Connectivity; Approved Standard – Second Edition
This document provides the framework for engineers to design devices, work stations, and interfaces that allow multiple types and brands of point-of-care devices to communicate bidirectionally with access points, data managers, and laboratory information systems from a variety of vendors. An NCCLS, IFCC, CIC joint publication.
Purchase here.

Our procedures have been designed to ensure that consensus has been achieved when a standard or guideline is published at the approved level. This means that a document has been rigorously reviewed by the authoring subcommittee, the area committee overseeing the project, the Board of Directors, and the medical-testing community that participates in the consensus process by carefully reviewing and commenting on the standard or guideline.

You may automatically receive or select approved-level documents as a member benefit.  Find out more about joining CLSI:  view membership options and benefits. [ return to top ]